x

Coronavirus

India Calls New UK COVID-19 Vaccine Rules “Discriminatory”

September 21, 2021

NEW DELHI — India says the British government’s decision not to recognize coronavirus vaccine certificates issued by Indian authorities is a “discriminatory policy” that will impact its citizens who want to travel to that country.

Foreign Secretary Harsh Vardhan Shringla says the new rules could force India to “impose reciprocal measures” if the matter is not resolved.

The new rules require Indians visiting the U.K to quarantine themselves for 10 days and undergo COVID-19 tests even if they are fully vaccinated with AstraZeneca vaccines made under license in India.

The rules take effect next month. India’s Serum Institute, which makes the AstraZeneca vaccine, has not applied for its approval by the European Union.

Most people in India have been vaccinated with the Indian-made AstraZeneca vaccine. Others have received COVAXIN, which is not used in Britain.

India, the world’s largest vaccine producer, said Monday it will resume exports and donations of surplus coronavirus vaccines in October after a several-month freeze due to a massive surge in domestic infections.

RELATED

BEIJING (AP) — Genetic material collected at a Chinese market near where the first human cases of COVID-19 were identified show raccoon dog DNA comingled with the virus, adding evidence to the theory that the virus originated from animals, not from a lab, international experts say.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.